n,n-dimethyl-n-hexadecyl-1-octadecylammonium has been researched along with docetaxel anhydrous in 1 studies
| Studies (n,n-dimethyl-n-hexadecyl-1-octadecylammonium) | Trials (n,n-dimethyl-n-hexadecyl-1-octadecylammonium) | Recent Studies (post-2010) (n,n-dimethyl-n-hexadecyl-1-octadecylammonium) | Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) |
|---|---|---|---|---|---|
| 14 | 0 | 8 | 12,110 | 3,216 | 6,920 |
| Protein | Taxonomy | n,n-dimethyl-n-hexadecyl-1-octadecylammonium (IC50) | docetaxel anhydrous (IC50) |
|---|---|---|---|
| Kinesin-like protein KIF11 | Homo sapiens (human) | 0.0014 | |
| Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | 5.0119 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardo, MCC; Braojo, IMP; Caballero, BB; Carrasco, JM; Fernández, BM; Guerrero, OV; Gutiérrez, ZA; Medina, EAG; Miguel, KL; Montero, YC; Ortiz, MR; Prado, YID; Rodríguez, LEM; Rubio, MC; Torres, KP; Tul, LEA; Varela, IGS | 1 |
1 other study(ies) available for n,n-dimethyl-n-hexadecyl-1-octadecylammonium and docetaxel anhydrous
| Article | Year |
|---|---|
Neoadjuvant Trastuzumab and Pertuzumab in Combination with Standard Chemotherapy for HER2-Positive Early Breast Cancer: Real-World Practice in Cuba.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cuba; Docetaxel; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prospective Studies; Receptor, ErbB-2; Trastuzumab | 2023 |